- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04949334
Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ruey Chen, PhD
- Phone Number: 8620 886-2-2249088
- Email: 18622@s.tmu.edu.tw
Study Contact Backup
- Name: Tzu-Ang Chen, MD
- Phone Number: 886-915855505
- Email: b101103035@tmu.edu.tw
Study Locations
-
-
-
New Taipei City, Taiwan, 235
- Recruiting
- Shuang Ho Hospital, Taipei Medical University
-
Contact:
- Ruey Chen, PhD
- Phone Number: 8620 886-2-2249088
- Email: 18622@s.tmu.edu.tw
-
Contact:
- Tzu-Ang Chen, MD
- Phone Number: 886-915855505
- Email: b101103035@tmu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ischemic stroke diagnosed by MRI
- Age over 20 years old
- No worsening of stroke or second stroke this time
Exclusion Criteria:
- Unable to understand instructions normally, or communication difficulties
- Patients with endotracheal tube or tracheostomy
- Angina in recent 3 months, myocardial infarction, heart failure
- Patients with asthma or chronic obstructive pulmonary disease, spontaneous pneumothorax, and ongoing pneumonia
- Patients with untreated hernias
- Pregnant
- Ongoing fever (body temperature>38.5°C)
- Poor hypertension control (higher than 170/100 mmHg three days before intervention)
- Patients who have had cerebral hemorrhage or aneurysm
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dofin Breathing Strength Builder
Usual post stroke care and respiratory muscle training
|
If the patient's condition is stable, respiratory muscle training will be performed under Dofin Breathing Strength Builder 7 days after stroke. The patient will receive respiratory muscle training by repetition of 30 times, two courses per day, x 7 days, for three weeks. The initial load was set at 30% of the participants' maximal baseline strength and increased weekly at intervals of 2 cmH2O. |
No Intervention: Usual post stroke care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Respiratory muscle function-1.1
Time Frame: Baseline
|
MEP (maximal expiratory pressure)
|
Baseline
|
Respiratory muscle function-1.2
Time Frame: Within one week after training
|
MEP (maximal expiratory pressure)
|
Within one week after training
|
Respiratory muscle function-1.3
Time Frame: Twelve weeks after training
|
MEP (maximal expiratory pressure)
|
Twelve weeks after training
|
Respiratory muscle function-2.1
Time Frame: Baseline
|
MIP (maximal inspiratory pressure)
|
Baseline
|
Respiratory muscle function-2.2
Time Frame: Within one week after training
|
MIP (maximal inspiratory pressure)
|
Within one week after training
|
Respiratory muscle function-2.3
Time Frame: Twelve weeks after training
|
MIP (maximal inspiratory pressure)
|
Twelve weeks after training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dyspnea.1
Time Frame: Baseline
|
Dyspnea assessed by Modified Borg Dyspnea Scale (MBS).
MBS can go from 0-10, 10 is the more severe condition.
|
Baseline
|
Dyspnea.2
Time Frame: Within one week after training
|
Dyspnea assessed by Modified Borg Dyspnea Scale (MBS).
MBS can go from 0-10, 10 is the more severe condition.
|
Within one week after training
|
Dyspnea.3
Time Frame: Twelve weeks after training
|
Dyspnea assessed by Modified Borg Dyspnea Scale (MBS).
MBS can go from 0-10, 10 is the more severe condition.
|
Twelve weeks after training
|
Exercise tolerance.1
Time Frame: Baseline
|
Exercise tolerance assessed by six-minute walk test (6MWT).
|
Baseline
|
Exercise tolerance.2
Time Frame: Within one week after training
|
Exercise tolerance assessed by six-minute walk test (6MWT).
|
Within one week after training
|
Exercise tolerance.3
Time Frame: Twelve weeks after training
|
Exercise tolerance assessed by six-minute walk test (6MWT).
|
Twelve weeks after training
|
Body composition.1
Time Frame: Baseline
|
Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
|
Baseline
|
Body composition.2
Time Frame: Within one week after training
|
Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
|
Within one week after training
|
Body composition.3
Time Frame: Twelve weeks after training
|
Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
|
Twelve weeks after training
|
Life quality.1
Time Frame: Baseline
|
Quality of life assessed by Short-form 12 (SF-12).
SF-12 can go from 0-100, 100 is the better life quality.
|
Baseline
|
Life quality.2
Time Frame: Within one week after training
|
Quality of life assessed by Short-form 12 (SF-12).
SF-12 can go from 0-100, 100 is the better life quality.
|
Within one week after training
|
Life quality.3
Time Frame: Twelve weeks after training
|
Quality of life assessed by Short-form 12 (SF-12).
SF-12 can go from 0-100, 100 is the better life quality.
|
Twelve weeks after training
|
Swallowing.1
Time Frame: Baseline
|
Swallowing function assessed by the Functional Oral Intake Scale (FOIS).
The score can go from 1-7, 7 is the better oral intake condition.
|
Baseline
|
Swallowing.2
Time Frame: Within one week after training
|
Swallowing function assessed by the Functional Oral Intake Scale (FOIS).
The score can go from 1-7, 7 is the better oral intake condition.
|
Within one week after training
|
Swallowing.3
Time Frame: Twelve weeks after training
|
Swallowing function assessed by the Functional Oral Intake Scale (FOIS).
The score can go from 1-7, 7 is the better oral intake condition.
|
Twelve weeks after training
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N202009012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke, Ischemic
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Bakken Research CenterCompletedCryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic StrokeNetherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
-
University Hospital, BrestCompletedStroke, Ischemic | Stroke HemorrhagicFrance
-
Umbria Bioengineering TechnologiesRecruitingStroke, Ischemic | Stroke HemorrhagicItaly
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Australia, Sweden, Canada, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, China, Greece, Japan, Turkey, Netherlands, Romania, United Kingdom, Portugal, Hungary, Italy, Brazil, France, S... and more
-
University of AlbertaCompletedTransient Ischemic Attack | Minor Ischemic StrokeCanada
-
Stephanie HarrisonActive, not recruitingTransient Ischemic Attack | Stroke, IschemicUnited Kingdom
Clinical Trials on Dofin Breathing Strength Builder
-
Universidade Camilo Castelo BrancoCompletedIn Brazil, Which Has an Increasing Number of Elderly People. | The Physiological Alterations of Aging Are Systemic.Brazil
-
Federal University of PelotasNot yet recruitingDepressive Symptoms | Anxiety Symptoms
-
Claude Bernard UniversityCompletedStress | Stress, Psychological | Communication | Stress, Physiological | Performance | Medical Education | Exam Stress | MindfulnessFrance
-
University of Nove de JulhoCompleted